Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Zeev's Turnips - No Politics -- Ignore unavailable to you. Want to Upgrade?

To: anon who wrote (2374)	10/31/2001 5:00:26 PM
From: Zeev Hed	Respond to of 99280

Yup, except for a flyer here and there, I just managed to get few OXGN here in the last hour between $2.50 and $2.85 (most at $2.60). They are selling at twice cash and have risen dramatically today, since they completed a phase I on Combretastatin, supposedly, like ENMD stuff, it stop the blood from getting to cancer tissue and starving the cancer. Very risky and very thin and already very much up on the day, but not too far from cash and book yet. If the news catches up it could easily go to four five times book, or about $6/$7. Zeev